{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T08:10:13Z","timestamp":1778227813020,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s11060-026-05507-5","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T16:51:06Z","timestamp":1776185466000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A differentiated thyroid carcinoma-specific graded prognostic assessment for brain metastases: derivation in a 10,306-patient cohort and external validation"],"prefix":"10.1007","volume":"177","author":[{"given":"Hamza A.","family":"Salim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarimar","family":"Agosto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba Al","family":"Qudah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Learned","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Zafereo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mimi I.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Msherghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naifa","family":"Busaidy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Eymen","family":"Ucisik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Hamidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussein","family":"Tawbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rami W.","family":"Eldaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Wintermark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria E.","family":"Cabanillas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"issue":"Suppl 1","key":"5507_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/cam4.4901","volume":"11","author":"T Alonso-Gordoa","year":"2022","unstructured":"Alonso-Gordoa T (2022) Multimodal approach to the treatment of patients with radioiodine refractory differentiated thyroid cancer and metastases to the central nervous system. Cancer Med 11(Suppl 1):33\u201339. https:\/\/doi.org\/10.1002\/cam4.4901","journal-title":"Cancer Med"},{"issue":"5","key":"5507_CR2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1056\/NEJM199801293380506","volume":"338","author":"MJ Schlumberger","year":"1998","unstructured":"Schlumberger MJ (1998) Papillary and follicular thyroid carcinoma. N Engl J Med 338(5):297\u2013306. https:\/\/doi.org\/10.1056\/NEJM199801293380506","journal-title":"N Engl J Med"},{"issue":"3","key":"5507_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10585-023-10208-8","volume":"40","author":"L Wolff","year":"2023","unstructured":"Wolff L, Steindl A, Popov P et al. (2023) Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer. Clin Exp Metastasis 40(3):217\u2013226. https:\/\/doi.org\/10.1007\/s10585-023-10208-8","journal-title":"Clin Exp Metastasis"},{"issue":"4","key":"5507_CR4","doi-asserted-by":"publisher","first-page":"e0154739","DOI":"10.1371\/journal.pone.0154739","volume":"11","author":"J Choi","year":"2016","unstructured":"Choi J, Kim JW, Keum YS, Lee IJ (2016) The largest known survival analysis of patients with brain metastasis from thyroid cancer based on prognostic groups. PLoS One 11(4):e0154739. https:\/\/doi.org\/10.1371\/journal.pone.0154739","journal-title":"PLoS One"},{"issue":"3","key":"5507_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.14670\/HH-18-277","volume":"36","author":"I Abe","year":"2021","unstructured":"Abe I, Lam AKY (2021) Anaplastic thyroid carcinoma: updates on WHO classification, clinicopathological features and staging. Histol Histopathol 36(3):239\u2013248. https:\/\/doi.org\/10.14670\/HH-18-277","journal-title":"Histol Histopathol"},{"issue":"11","key":"5507_CR6","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1210\/jcem.82.11.4386","volume":"82","author":"AC Chiu","year":"1997","unstructured":"Chiu AC, Delpassand ES, Sherman SI (1997) Prognosis and treatment of brain metastases in thyroid carcinoma. J Clin Endocrinol Metab 82(11):3637\u20133642. https:\/\/doi.org\/10.1210\/jcem.82.11.4386","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"5507_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/BF01058357","volume":"22","author":"BM Biswal","year":"1994","unstructured":"Biswal BM, Bal CS, Sandhu MS, Padhy AK, Rath GK (1994) Management of intracranial metastases of differentiated carcinoma of thyroid. J Neurooncol 22(1):77\u201381. https:\/\/doi.org\/10.1007\/BF01058357","journal-title":"J Neurooncol"},{"key":"5507_CR8","doi-asserted-by":"publisher","first-page":"e888","DOI":"10.1016\/j.wneu.2017.12.172","volume":"111","author":"M Chen","year":"2018","unstructured":"Chen M, Chen D, Xu J, Xu M, Zhong P (2018) Management of solitary intracranial metastases of differentiated thyroid carcinoma: 11 pathologically confirmed cases and systematic literature Review. World Neurosurg 111:e888\u2013e894. https:\/\/doi.org\/10.1016\/j.wneu.2017.12.172","journal-title":"World Neurosurg"},{"key":"5507_CR9","doi-asserted-by":"publisher","first-page":"107639","DOI":"10.1016\/j.clineuro.2023.107639","volume":"227","author":"MA Gubbiotti","year":"2023","unstructured":"Gubbiotti MA, Livolsi V (2023) Brain metastases of papillary thyroid carcinoma origin are derived from aggressive histologic variants and demonstrate similar adverse morphology in the metastatic lesion. Clin Neurol Neurosurg 227:107639. https:\/\/doi.org\/10.1016\/j.clineuro.2023.107639","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"5507_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13044-023-00146-8","volume":"16","author":"LN Ha","year":"2023","unstructured":"Ha LN, Khanh LQ, Hanh NTM, Seo HJ, Son MH (2023) Screening and treatment of brain metastasis from papillary thyroid carcinoma: a case series. Thyroid Res 16(1):1. https:\/\/doi.org\/10.1186\/s13044-023-00146-8","journal-title":"Thyroid Res"},{"issue":"2","key":"5507_CR11","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1089\/thy.2013.0061","volume":"24","author":"H de Figueiredo B","year":"2014","unstructured":"de Figueiredo B H, Godbert Y, Soubeyran I et al. (2014) Brain metastases from thyroid carcinoma: a retrospective study of 21 patients. Thyroid Off J Am Thyroid Assoc 24(2):270\u2013276. https:\/\/doi.org\/10.1089\/thy.2013.0061","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"issue":"5","key":"5507_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0936-6555(05)80722-8","volume":"8","author":"P Hjiyiannakis","year":"1996","unstructured":"Hjiyiannakis P, Jefferies S, Harmer CL (1996) Brain metastases in patients with differentiated thyroid carcinoma. Clin Oncol 8(5):327\u2013330. https:\/\/doi.org\/10.1016\/S0936-6555(05)80722-8","journal-title":"Clin Oncol"},{"issue":"3","key":"5507_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s11060-008-9783-2","volume":"93","author":"IY Kim","year":"2009","unstructured":"Kim IY, Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD (2009) Gamma knife radiosurgery for metastatic brain tumors from thyroid cancer. J Neurooncol 93(3):355\u2013359. https:\/\/doi.org\/10.1007\/s11060-008-9783-2","journal-title":"J Neurooncol"},{"issue":"3","key":"5507_CR14","doi-asserted-by":"publisher","first-page":"292","DOI":"10.5114\/fn.2022.118608","volume":"60","author":"B Kleinschmidt-DeMasters","year":"2022","unstructured":"Kleinschmidt-DeMasters B, Marshall C (2022) Thyroid carcinoma metastases to central nervous system and vertebrae. Folia Neuropathol 60(3):292\u2013300. https:\/\/doi.org\/10.5114\/fn.2022.118608","journal-title":"Folia Neuropathol"},{"issue":"12","key":"5507_CR15","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1007\/s00701-015-2611-5","volume":"157","author":"HS Lee","year":"2015","unstructured":"Lee HS, Yoo H, Lee SH, Gwak HS, Shin SH (2015) Clinical characteristics and follow-up of intracranial metastases from thyroid cancer. Acta Neurochir (Wien) 157(12):2185\u20132194. https:\/\/doi.org\/10.1007\/s00701-015-2611-5","journal-title":"Acta Neurochir (Wien)"},{"issue":"2","key":"5507_CR16","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/cncr.11488","volume":"98","author":"RR McWilliams","year":"2003","unstructured":"McWilliams RR, Giannini C, Hay ID, Atkinson JL, Stafford SL, Buckner JC (2003) Management of brain metastases from thyroid carcinoma: a study of 16 pathologically confirmed cases over 25 years. Cancer 98(2):356\u2013362. https:\/\/doi.org\/10.1002\/cncr.11488","journal-title":"Cancer"},{"issue":"2","key":"5507_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/BF02988589","volume":"14","author":"T Misaki","year":"2000","unstructured":"Misaki T, Iwata M, Kasagi K, Konishi J (2000) Brain metastasis from differentiated thyroid cancer in patients treated with radioiodine for bone and lung lesions. Ann Nucl Med 14(2):111\u2013114. https:\/\/doi.org\/10.1007\/BF02988589","journal-title":"Ann Nucl Med"},{"issue":"2","key":"5507_CR18","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1177\/030089169508100214","volume":"81","author":"M Salvati","year":"1995","unstructured":"Salvati M, Cervoni L, Celli P (1995) Solitary brain metastases from thyroid carcinoma: study of 6 cases. Tumori 81(2):142\u2013143. https:\/\/doi.org\/10.1177\/030089169508100214","journal-title":"Tumori"},{"issue":"2","key":"5507_CR19","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1177\/030089169708300226","volume":"83","author":"AM Samuel","year":"1997","unstructured":"Samuel AM, Shah DH (1997) Brain metastases in well-differentiated carcinoma of the thyroid. Tumori 83(2):608\u2013610. https:\/\/doi.org\/10.1177\/030089169708300226","journal-title":"Tumori"},{"issue":"6","key":"5507_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1530\/EC-16-0049","volume":"5","author":"J Sim\u00f5es-Pereira","year":"2016","unstructured":"Sim\u00f5es-Pereira J, Macedo D, Bugalho MJ (2016) Clinical outcomes of a cohort of patients with central nervous system metastases from thyroid cancer. Endocr Connect 5(6):82\u201388. https:\/\/doi.org\/10.1530\/EC-16-0049","journal-title":"Endocr Connect"},{"issue":"1","key":"5507_CR21","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3892\/ol.2017.7325","volume":"15","author":"I Slutzky-Shraga","year":"2018","unstructured":"Slutzky-Shraga I, Gorshtein A, Popovitzer A et al. (2018) Clinical characteristics and disease outcome of patients with non-medullary thyroid cancer and brain metastases. Oncol Lett 15(1):672\u2013676. https:\/\/doi.org\/10.3892\/ol.2017.7325","journal-title":"Oncol Lett"},{"issue":"4","key":"5507_CR22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00428-013-1394-4","volume":"462","author":"FC Tahmasebi","year":"2013","unstructured":"Tahmasebi FC, Farmer P, Powell SZ et al. (2013) Brain metastases from papillary thyroid carcinomas. Virchows Arch Int J Pathol 462(4):473\u2013480. https:\/\/doi.org\/10.1007\/s00428-013-1394-4","journal-title":"Virchows Arch Int J Pathol"},{"issue":"5","key":"5507_CR23","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3892\/mco.2013.139","volume":"1","author":"K Tsuda","year":"2013","unstructured":"Tsuda K, Tsurushima H, Takano S, Tsuboi K, Matsumura A (2013) Brain metastasis from papillary thyroid carcinomas. Mol Clin Oncol 1(5):817\u2013819. https:\/\/doi.org\/10.3892\/mco.2013.139","journal-title":"Mol Clin Oncol"},{"issue":"11","key":"5507_CR24","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.eprac.2023.08.003","volume":"29","author":"SS Wu","year":"2023","unstructured":"Wu SS, Lamarre ED, Scharpf J et al. (2023) Survival outcomes of advanced thyroid cancer enriched in brain metastases following treatment with small molecule inhibitors. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol 29(11):881\u2013889. https:\/\/doi.org\/10.1016\/j.eprac.2023.08.003","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"key":"5507_CR25","doi-asserted-by":"publisher","first-page":"730025","DOI":"10.3389\/fendo.2021.730025","volume":"12","author":"T Wu","year":"2021","unstructured":"Wu T, Jiao Z, Li Y et al. (2021) Brain metastases from differentiated thyroid carcinoma: a retrospective study of 22 patients. Front Endocrinol 12:730025. https:\/\/doi.org\/10.3389\/fendo.2021.730025","journal-title":"Front. Endocrinol"},{"issue":"5","key":"5507_CR26","doi-asserted-by":"publisher","first-page":"e220087","DOI":"10.1530\/ETJ-22-0087","volume":"11","author":"J Yoo","year":"2022","unstructured":"Yoo J, Kim HJ, Kim SM, Park HH (2022) Prognostic factors to predict the efficacy of surgical interventions against brain metastasis secondary to thyroid cancer. Eur Thyroid J 11(5):e220087. https:\/\/doi.org\/10.1530\/ETJ-22-0087","journal-title":"Eur Thyroid J"},{"key":"5507_CR27","doi-asserted-by":"publisher","unstructured":"Zhang R, Li W, Wang H et al. Incidence and gender difference of brain metastases in newly diagnosed follicular thyroid cancer patients. Eur Thyroid J ETJ-24\u20130093. https:\/\/doi.org\/10.1530\/ETJ-24-0093. Published online November 1, 2024","DOI":"10.1530\/ETJ-24-0093"},{"issue":"4","key":"5507_CR28","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/s0360-3016(96)00619-0","volume":"37","author":"L Gaspar","year":"1997","unstructured":"Gaspar L, Scott C, Rotman M et al. (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation therapy Oncology group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37(4):745\u2013751. https:\/\/doi.org\/10.1016\/s0360-3016(96)00619-0","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"5507_CR29","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ijrobp.2007.06.074","volume":"70","author":"PW Sperduto","year":"2008","unstructured":"Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W (2008) A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1, 960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 70(2):510\u2013514. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.06.074","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"5507_CR30","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1200\/JCO.2011.38.0527","volume":"30","author":"PW Sperduto","year":"2012","unstructured":"Sperduto PW, Kased N, Roberge D et al. (2012) Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol Off J Am Soc Clin Oncol 30(4):419\u2013425. https:\/\/doi.org\/10.1200\/JCO.2011.38.0527","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"4","key":"5507_CR31","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.ijrobp.2017.06.2454","volume":"99","author":"PW Sperduto","year":"2017","unstructured":"Sperduto PW, Jiang W, Brown PD et al. (2017) Estimating survival in Melanoma patients with brain metastases: an update of the graded prognostic assessment for melanoma using molecular markers (Melanoma-molGPA). Int J Radiat Oncol Biol Phys 99(4):812\u2013816. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.06.2454","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"5507_CR32","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/j.ijrobp.2011.02.027","volume":"82","author":"PW Sperduto","year":"2012","unstructured":"Sperduto PW, Kased N, Roberge D et al. (2012) The effect of tumor Subtype on survival and the Graded prognostic Assessment (GPA) for patients with breast cancer and brain metastases. Int J Radiat Oncol Biol Phys 82(5):2111\u20132117. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.02.027","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"5507_CR33","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1210\/js.2018-00241","volume":"3","author":"CJ Gomes-Lima","year":"2018","unstructured":"Gomes-Lima CJ, Wu D, Rao SN et al. (2018) Brain metastases from differentiated thyroid carcinoma: prevalence, Current therapies, and outcomes. J Endocr Soc 3(2):359\u2013371. https:\/\/doi.org\/10.1210\/js.2018-00241","journal-title":"J Endocr Soc"},{"issue":"5","key":"5507_CR34","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3803\/EnM.2022.1553","volume":"37","author":"CK Jung","year":"2022","unstructured":"Jung CK, Bychkov A, Kakudo K (2022) Update from the 2022 World health organization classification of thyroid tumors: a standardized diagnostic approach. Endocrinol Metab 37(5):703\u2013718. https:\/\/doi.org\/10.3803\/EnM.2022.1553","journal-title":"Endocrinol Metab"},{"issue":"2","key":"5507_CR35","doi-asserted-by":"publisher","first-page":"e220021","DOI":"10.1530\/ETJ-22-0021","volume":"11","author":"J Tong","year":"2022","unstructured":"Tong J, Ruan M, Jin Y et al. (2022) Poorly differentiated thyroid carcinoma: a clinician\u2019s perspective. Eur Thyroid J 11(2):e220021. https:\/\/doi.org\/10.1530\/ETJ-22-0021","journal-title":"Eur Thyroid J"},{"issue":"7","key":"5507_CR36","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/RLU.0000000000002618","volume":"44","author":"JR Osborne","year":"2019","unstructured":"Osborne JR, Kondraciuk JD, Rice SL et al. (2019) Thyroid cancer brain metastasis: survival and genomic characteristics of a large tertiary care cohort. Clin Nucl Med 44(7):544\u2013549. https:\/\/doi.org\/10.1097\/RLU.0000000000002618","journal-title":"Clin Nucl Med"},{"issue":"3","key":"5507_CR37","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","volume":"159","author":"N Agrawal","year":"2014","unstructured":"Agrawal N, Akbani R, Aksoy BA et al. (2014) Integrated Genomic Characterization of papillary thyroid carcinoma. Cell 159(3):676\u2013690. https:\/\/doi.org\/10.1016\/j.cell.2014.09.050","journal-title":"Cell"},{"issue":"2","key":"5507_CR38","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1089\/thy.2015.0227","volume":"26","author":"M Afkhami","year":"2016","unstructured":"Afkhami M, Karunamurthy A, Chiosea S et al. (2016) Histopathologic and clinical Characterization of thyroid tumors carrying the BRAF(K601E) mutation. Thyroid off J Am Thyroid Assoc 26(2):242\u2013247. https:\/\/doi.org\/10.1089\/thy.2015.0227","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"issue":"3","key":"5507_CR39","doi-asserted-by":"publisher","first-page":"R143","DOI":"10.1530\/ERC-15-0533","volume":"23","author":"R Liu","year":"2016","unstructured":"Liu R, Xing M (2016) TERT promoter mutations in thyroid cancer. Endocr Relat Cancer 23(3):R143\u2013R155. https:\/\/doi.org\/10.1530\/ERC-15-0533","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"5507_CR40","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1172\/JCI85271","volume":"126","author":"I Landa","year":"2016","unstructured":"Landa I, Ibrahimpasic T, Boucai L et al. (2016) Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J Clin Invest 126(3):1052\u20131066. https:\/\/doi.org\/10.1172\/JCI85271","journal-title":"J. Clin. Invest"},{"issue":"8","key":"5507_CR41","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1089\/thy.2020.0947","volume":"31","author":"A Bunevicius","year":"2021","unstructured":"Bunevicius A, Fribance S, Pikis S et al. (2021) Stereotactic radiosurgery for differentiated thyroid cancer brain metastases: an international, multicenter study. Thyroid Off J Am Thyroid Assoc 31(8):1244\u20131252. https:\/\/doi.org\/10.1089\/thy.2020.0947","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"5507_CR42","doi-asserted-by":"publisher","unstructured":"Harries V, Eagan A, Tuttle RM et al. The surgical Management of intracranial metastasis secondary to follicular cell-derived thyroid carcinoma. J Surg Oncol. n\/a(n\/a). doi: https:\/\/doi.org\/10.1002\/jso.27883","DOI":"10.1002\/jso.27883"},{"issue":"10","key":"5507_CR43","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1016\/j.radcr.2023.07.025","volume":"18","author":"SA Asim","year":"2023","unstructured":"Asim SA, Elashaal AA (2023) Metastasis of lung adenocarcinoma to the pituitary gland. Radiol Case Rep 18(10):3487\u20133491. https:\/\/doi.org\/10.1016\/j.radcr.2023.07.025","journal-title":"Radiol Case Rep"},{"issue":"3","key":"5507_CR44","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s11102-020-01034-2","volume":"23","author":"K Lithgow","year":"2020","unstructured":"Lithgow K, Siqueira I, Senthil L et al. (2020) Pituitary metastases: presentation and outcomes from a pituitary center over the last decade. Pituitary 23(3):258\u2013265. https:\/\/doi.org\/10.1007\/s11102-020-01034-2","journal-title":"Pituitary"},{"issue":"2","key":"5507_CR45","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1210\/js.2018-00241","volume":"3","author":"CJ Gomes-Lima","year":"2019","unstructured":"Gomes-Lima CJ, Wu D, Rao SN et al. (2019) Brain metastases from differentiated thyroid carcinoma: prevalence, Current therapies, and outcomes. J Endocr Soc 3(2):359\u2013371. https:\/\/doi.org\/10.1210\/js.2018-00241","journal-title":"J Endocr Soc"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05507-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05507-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05507-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:15:40Z","timestamp":1778224540000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05507-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["5507"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05507-5","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with relevant guidelines and regulations and approved by The University of Texas MD Anderson Cancer Center Institutional Review Board. The requirement for informed consent was waived due to the retrospective nature of the study and use of de-identified data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"105"}}